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a  b  s  t  r  a  c  t
Wiskott–Aldrich  syndrome  (WAS)  is  a condition  with  variable  expression,  which  causes  persistent  throm-
bocytopenia  and,  in  its  complete  form,  also  causes  small  platelets  and  humoral  immunodeﬁciency.  A
14-year-old  boy,  diagnosed  with  WAS  but never  treated,  presented  with  symptoms  of  heart  and  renal  fail-
ure.  His  right  buccal  region  was  swollen  and  his  right  ﬁrst molar  showed  a  cyst-like  image  on  dental  X-rayeywords:
ntreated Wiskott–Aldrich syndrome
WAS)
hole-body management
nvasive  treatment
ral  and maxillofacial surgery
ﬁlms.  The  boy’s  symptoms  were  attributed  to  an  infected  cyst,  greatly  aggravated  by WAS-related  immun-
odeﬁciency.  The  boy  was  sedated  and  the  affected  tooth  and  cyst  were  enucleated.  Invasive  treatment
was  safely  achieved  by paying  close  attention  to  whole-body  management.
Crown Copyright ©  2012 Published by Elsevier Ltd on behalf of Japanese Stomatological Society.
 All rights reserved.. Introduction
Wiskott–Aldrich syndrome (WAS) is a congenital X-linked
mmunodeﬁciency characterized by frequent infections, thrombo-
ytopenia with small platelets, eczema, and an increased risk of
utoimmune disorders and malignancies [1]. The syndrome was
amed after Robert Anderson Aldrich [2], an American pediatri-
ian who described the disease in a family of Dutch–Americans
n 1954, and Alfred Wiskott [3], a German pediatrician who  ﬁrst
oticed the syndrome in 1937. Resulting from thrombocytopenia,
he ﬁrst signs of WAS  are usually petechiae and bruising. In 1994,
AS was linked to mutations in a gene on the short arm of the
 chromosome, encoding the WAS  protein [4]. Thus, an attractive
ption for treating WAS  is gene therapy, which leads to a complete
ure.
Untreated patients with typical WAS  have a poor prognosis with
nfections, bleeding, lymphoproliferative disorders, and malignan-
ies being the most common causes of death. The life span of
 typical patient is quite short, with an expected mean survival
ime of 6.5 years from birth [5]. We  report a 14-year-old boy
ith untreated WAS  who underwent a successful mandibular
stectomy.∗ Corresponding author. Tel.: +81 92 801 1011x3537; fax: +81 92 801 1044.
E-mail  address: rkita@minf.med.fukuoka-u.ac.jp (R. Kita).
348-8643/$ – see front matter. Crown Copyright ©  2012 Published by Elsevier Ltd on be
ttp://dx.doi.org/10.1016/S1348-8643(12)00048-12. Case report
A  14-year-old boy with severe symptoms of cardiac and renal
failure was brought to the emergency center of our hospital in an
ambulance. At 4 months of age, he had developed blood platelet
degradation and hepatomegaly, and was diagnosed with WAS. He
frequently developed epistaxis, which was stopped by inserting a
0.001% epinephrine plug into the affected nostril. His parents were
informed that he required bone marrow transplantation, but they
refused this treatment. The patient exhibited some delay of men-
tal development, but did not manifest any neurological or physical
developmental abnormalities.
When  the patient arrived at the emergency room, his
hemoglobin and hematocrit levels were extremely low (Table 1). A
chest radiograph showed bilateral pulmonary edema (Fig. 1) and an
ultrasound cardiogram showed that the ventricular ejection frac-
tion was 40%. A large swelling was observed in his right buccal
region and his right ﬁrst molar had severe caries; a cyst-like image
was observed in the apical area of that tooth (Fig. 2a). The boy’s
symptoms were attributed to an infected cyst, greatly aggravated
by the immune deﬁciency caused by WAS.
After hospitalization, antibiotics were administered intra-
venously and local irrigations with water and povidone-iodine
were performed, regularly. The boy was placed on a renal disease
diet of 1700 kcal, containing 30 g of protein, and his water intake
was limited to 500 mL/day. He received intravenous antibiotics
and a blood transfusion. His general condition improved gradually,
and he was  moved from the emergency room to a pediatric ward
(Fig. 3).
half of Japanese Stomatological Society. All rights reserved.
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Table  1
Changes in perioperative laboratory values.
Days of
hospitalization
1  (ER) 13  (Pediatric ward) 35 (Preoperative day) 36 (Post platelet transfusion) 37 (POD1) 43 (POD7) 56 (POD24)
WBC  9.3 4.5 4 2.8 3.7 4.1 4.9
RBC 99 178 186 170 182 212 181
Hb  2.7 5.2 5.3 4.9 5.1 5.9 4.8
Plt  4.7 1 1.3 6.8 6.9 1.4 1.4
BUN  68 33 28 26 38 58
Cr 7.5  4.8 2.5 2.8 3.8 5.2
K 6.4  5.2 4 4.8 5.2 4.5
CRP 12 0.2 0.6 0.7 0.2 1.7
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bR, emergency room; POD, postoperative day; WBC, white blood cell (1000/L); RB
rea nitrogen (mg/dL); Cr, creatinine (mg/dL); K, potassium (meq/L); CRP: C-reactiv
A cystectomy was necessary to eliminate the cause of the local
nﬂammation, but it was impossible because of the renal failure
nd parents’ refusal to allow initiation of dialysis. Under hospital
ontrol, the patient’s renal function was gradually improved with
he restricted diet, limited water intake (700 mL/day), and inter-
al use of sodium polystyrene sulfonate. After the patient’s general
ondition improved, a cystectomy was planned for Day 36, post-
ospitalization.
Intravenous administration of cefotaxime (1.0 g/day) was
tarted 6 days before the operation and was changed to intravenous
dministration of sulbactam/ampicillin (1.5 g/day), beginning on
he ﬁnal preoperative day. The patient received a 200 mL  trans-
usion of blood platelets 2 days prior to surgery and again
mmediately before surgery. Immediately before the operation, the
atient’s hemoglobin value was 4.9 g/dL, and his platelet count was
8,000/L (Table 1).
The  affected tooth and cyst were enucleated after inducing
eep, intravenous sedation (propofol and midazolam) and apply-
ng a local anesthesia (3% mepivacaine without epinephrine).
tandard intraoperative monitoring involved electrocardiography,
on-invasive blood pressure monitoring, and measurements of
he heart rate and oxygen saturation. Supplemental oxygen was
dministered with a nasal cannula. For sedation, a bolus dose
ig. 1. Chest X-ray ﬁndings. There was a signiﬁcant ﬁnding of cardiomegaly and
ilateral pulmonary edema. blood cell (1000/L); Hb, hemoglobin (g/dL); Plt, platelet (10,000/L); BUN, blood
tein (mg/dL).
of 10 mg  propofol was administered intravenously. Sedation was
maintained by administering a continuous infusion of 2 mg/kg/h
propofol, which was  aimed at achieving the Observer’s Assessment
of Alertness/Sedation scale of 10–12/20. In this case, we  adminis-
tered 1 mg  midazolam when body movements occurred; this was
followed by administration of 4 mg/kg/h propofol. The total amount
of propofol and midazolam administered was  138 mg and 1 mg,
respectively. First, 3.6 mL  of local anesthetic was used and an addi-
tional 1.8 mL  was  administered during curettage. The operation
was completed safely and without any complications; the surgical
time was 50 min, and the duration of sedation was 70 min  (Fig. 2b).
Post-surgically, the wound was  kept open with an atelocollagen
sheet in the wounded area and packed with gauze (Fig. 4a); a plas-
tic protective cover was also kept in place for 2 weeks. The blood
clot under the plastic protective cover was weak (Fig. 4b), but no
deﬂuvium of the clot or postoperative bleeding occurred.
The  postoperative course of the oral wound was  good (Fig. 4c
and d), without the development of any gingival necrosis. On the
ninth postoperative day, a bacterial infection occurred in a left ankle
arthrosis, and antibiotics were administered (Fig. 3). The patient
was discharged 24 days after the operation with an epithelialized
wound region (Fig. 4e and f).
3. Discussion
The patient exhibited a range of symptoms, including increased
susceptibility to infection, renal insufﬁciency, abnormal hemostasis
due to thrombopenia, local necrosis caused by anemia, and nonco-
operation due to intellectual disability. It was also necessary to limit
the patient’s water intake and maintain strict dietary restrictions
in order to correct electrolyte imbalances and prevent aggravation
of renal dysfunction. These challenges warranted a re-evaluation of
the procedures that might be used more routinely to treat similar
conditions in other patients.
The threshold for prophylactic platelet transfusion for an inva-
sive procedure is a blood platelet count of 50,000/L or less. If a
patient has a blood platelet count of 10,000–20,000/L, an opera-
tion such as a tooth extraction can normally be performed safely
with local hemostasis. This patient seemed to experience epis-
taxis when his platelet counts fell below 15,000/L. In this case,
the patient received preoperative platelet transfusions to prevent
bleeding and postoperative development of anemia.
Most local anesthetics have inherent vasodilating effects. In
the case of local anesthetics injected into the highly vascular oral
tissues, an adequate effect is not obtained due to rapid diffu-
sion. Vasoconstrictors, mixed with local anesthetics, are used to
increase the duration of local anesthesia by constricting the blood
vessels, thus making it safe to use the anesthetic agent for an
extended duration and reducing the risk of hemorrhage [6,7,8].
Both epinephrine and felypressin are used as vasoconstrictors for
the oral area, in Japan, and both may  induce necrosis when used
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Fig. 2. Panoramic X-ray ﬁndings. A cyst-like image is observed in the apical area of the right ﬁrst molar.
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eig. 3. Summary of the therapeutic procedure. We administered the antimicrob
iperacillin/tazobactam; CTX, cefataxime; SBT/ABPC, sulbactam/ampicillin; MINO, 
n anemic tissues. Mepivacaine hydrochloride is an amide-type of
ocal anesthetic that has a reasonably rapid onset and a medium
uration of action. Because mepivacaine does not have a vasodi-
ating effect, the addition of a vasoconstrictor is unnecessary. For
hese reasons, mepivacaine was used as the local anesthetic, which
elped to minimize the risk of delayed wound healing due to local
nemia.
The patient was uncooperative while undergoing treatment,
efusing to open his mouth even for the daily, local irrigations.
eneral anesthesia was considered to be a high risk, based on the
ig. 4. Photograph of the postoperative course. (a) Immediately after surgery. The wound
nder  the plastic protective cover was weak. (c) Postoperative second week. The wound 
pithelization tendency. (e) Period of discharge. We  recognized epithelization. (f) One moents and performed transfusion appropriately. ER, emergency room; PIPC/TAZ,
ycline.
evaluation of his general condition. Therefore, intravenous seda-
tion was performed to avoid undue cardiac stress and to facilitate
patient cooperation. Propofol is the sedative of choice for these pro-
cedures because it is metabolized mainly by the liver [5,6], thereby
reducing the burden on the patient’s kidneys. No side effects, such
as respiratory depression, vomiting, or excessive sedation, were
observed.
Thus, using a combination of procedures, mandibular cystec-
tomy was successfully performed in a patient with untreated
WAS.
 was kept open and packed with gauze. (b) Postoperative ﬁrst week. The blood clot
was packed with gauze for 2 weeks. (d) Postoperative 17th day. We recognized an
nth after the surgery. We can see wound healing.
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